期刊文献+

构建一种可评价脂肪间充质干细胞成骨向分化的荧光素酶报告系统 被引量:1

Establishing a luciferase reporter system to evaluate osteogenic differentiation potential of human adipose-derived stem cells
下载PDF
导出
摘要 目的:构建一种可用于评价人脂肪间充质干细胞(human adipose-derived stem cells,h ASCs)成骨向分化的荧光素酶报告系统,以期能够快捷、特异且定量的检测出细胞在体外的成骨向分化情况,并且使将来活体监测小型实验动物外源移植细胞的成骨分化成为可能。方法:将骨钙素(osteocalsin,OC)基因的启动子克隆到荧光素酶luciferase报告基因的上游,构建p LVX-OC_(pro)-Luc-Puro载体,进行慢病毒包装后感染人脂肪间充质干细胞,嘌呤霉素(puromycin)筛选阳性克隆,获得稳定整合OC_(pro)-Luc-Puro的细胞株,将该细胞在成骨诱导培养基中培养的第7和14天,观察其在成骨诱导环境下分化的情况。在成骨诱导培养的第7和14天检测荧光素酶的活性,同时进行茜素红(Alizarin red S)染色定量及成骨相关基因表达水平的检测,通过比较验证该荧光素酶报告系统用于成骨评价的可行性。结果:成功构建p LVX-OC_(pro)-Luc-Puro载体获得稳定整合报告基因的h ASCs细胞株。在OC_(pro)-Luc-Puroh ASCs成骨诱导的第7和14天,茜素红钙化结节染色结果均为阳性,且第14天的染色及定量结果明显强于第7天。OC、Runx2及碱性磷酸酶(alkaline phosphatase,ALP)基因的mRNA水平在成骨分化刺激下,其表达水平逐渐上升,同时,荧光素酶被激活,且荧光素酶的活性在第14天明显强于第7天,即荧光素酶表达的趋势与茜素红染色定量及成骨相关基因表达水平一致。结论:成功构建了一种可用于评价成骨向分化的荧光素酶报告系统,并通过与传统的检测成骨向分化方法(茜素红染色定量、成骨相关基因表达)对比,验证了该系统的有效性。 Objective: Human adipose-derived stem cells (hASCs) are a highly attractive source in bone tissue engineering. To generate a luciferase reporter system that could be used to quantitatively and rapidly examine osteogenic differentiation potential of human adipose-derived stern cells (hASCs) in vitro, and eventually make it possible to monitor the osteogenic differentiation of transplanted cells in vi-vo. Methods: The genomic DNA harboring promotor regions of osteocalcin and DNA sequences encoding luciferase genes were amplified by PCR and cloned into the pLVX-pTRE-puro vector to generate the OCpro-Luc-Puro construct. Then, the OCpro-Luc-Puro construct together with three assistant vectors: pM- DLg/pRRE, pRSV-REV, and pVSVG, were transiently transfected into HEK293T cells followed by viral supernatants collection, filtration and concentration. Next, the hASCs stably expressing luciferase repor- ter gene driven by osteocalcin promotor were created with the lentivirus carrying OCpro-Luc-Puro cassette under puromycin selection. The OCpro-Luc-hASCs were then cultured in the absence or presence of osteo- genic differentiation medium. On the 7th and 14th days, after osteogenic induction, cellular extracts were collected and analyzed by luciferase reporter assay. Meanwhile, alizarin red staining and quantification as well as quantitative reverse transcription PCR (qRT-PCR) analysis of osteogenic associated genes osteo- calcin (OC), runt-related transcription factor 2 (Runx2) and alkaline phosphatase (ALP) were used to assess the osteogenic differentiation ability of OCpro-Luc-hASCs. Results: OCpro-Luc-Puro plasmid and OCpro-Luc-hASCs were successfully generated. On the 7th and 14th days after osteogenic induction, the luciferase activity of the cellular extracts from OC ro-Luc-hASCs was dramatically increased. Consistently, the extracellular matrix mineralization, as shown my Alizarin red S (ARS) staining and quantification was also markedly intensified and a marked increase of the mRNA expression levels of OC, Runx2 and ALP,although to variable extent, was observed upon osteogenic differentiation. These results indicated that the observations from traditional experiments examining hASCs osteogenic differentiation were largely in agreement with that of our luciferase reporter assay in OCpro-Luc-hASCs. Conclusion: We established a luciferase reporter system that could be used to rapidly, quantitatively and specifically determine osteo- genic differentiation ability of hASCs. Comparing with the traditional time-consuming methods, the system we generated here was highly effective. This system not only can be used to examine ostogenic differentia- tion of hASCs in a high throughput manner, but also provides a way to monitor ostogenic differentiation of cells in vivo.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2016年第1期170-174,共5页 Journal of Peking University:Health Sciences
基金 国家自然科学基金(81200763)资助~~
关键词 荧光素酶类 脂肪组织 间充质干细胞 骨生成 细胞分化 Luciferases Adipose tissue Mesenchymal stromal cells 0steogenesis Cell differentiation
  • 相关文献

参考文献15

  • 1Montjovent MO, Burri N, Mark S, et aJ. Fetal bone cells for tissue engineering[J]. Bone, 2004, 35(6): 1323 - 1333.
  • 2Moshaverinia A, Ansari S, Chen C, et al. Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering[J]. Biomaterials, 2013,34(28): 6572 -6579.
  • 3Yamada Y, Nakamura S, Ito K, et aJ. Injectable bone tissue engineering using expanded mesenchymal stem cells[J]. Stem Cells, 2013, 31 (3) : 572 -580.
  • 4Ge W, Shi L, Zhou Y, et al. Inhibition of osteogenic differentiation of human adipose-derived stromal cells by retinoblastoma binding protein 2 repression of RUNX2-activated transcription[J] . Stem Cells, 2011, 29(7) : 1112 -1125.
  • 5Kim HK, Cho SG, KimJH, et al. Mevinolin enhances osteogenic genes ( ALP, type I collagen and osteocalcin), CD44, CD4 7 and CD51 expression during osteogenic differentiation[J]. Life Sci, 2009, 84(9/10): 290 -295.
  • 6Wise LD, Winkelmann CT. Evaluation of hydroxyurea-induced fetal skeletal changes in Dutch belted rabbits by micro-computed tomography and alizarin red staining[J]. Birth Defects Res B Dev Reprod Toxicol, 2009, 86(3): 220 -226.
  • 7Ronay V, Belibasakis GN, Attin T, et al. Expression of embryonic stem cell markers and osteogenic differentiation potential in cells derived from periodontal granulation tissue[J]. Cell Bioi Int , 2014, 38(2): 179 -186.
  • 8Grabley S, Thiericke R. Bioactive agents from natural sources: trends in discovery and application[J]. Adv Biochem Eng Biotechnol, 1999,64: 101 -154.
  • 9Varble A, Benitez AA, Schmid S, et al. An in vivo RNAi screening approach to identify host determinants of virus replication[J]. Cell Host Microbe, 2013, 14 (3) : 346 - 356.
  • 10W uJH, Zhang SH, Gao FJ, et al. RN Ai screening identifies GSK3beta as a regulator of DRPI and the neuroprotection of lithium chloride against elevated pressure involved in down regulation of DRPI[J]. N eurosci Lett, 2013, 554: 99 - 104.

二级参考文献65

  • 1林云锋,敬伟,陈希哲,乔鞠,李志勇,严征斌,吴凌,田卫东.绿色荧光蛋白标记人脂肪基质细胞成骨分化能力体外实验研究[J].四川大学学报(医学版),2006,37(5):700-703. 被引量:1
  • 2Contag P R, Olomu I N, Stenvenson D K, et al. Bioluminescent indicators in living mammals. Nat Med,1998, 4(2):245-247.
  • 3Ntziachristos V, Ripoll J, Wang L V, et al. Looking and listenting to light: the evolution of whole-body photonic imaging. Nat Biotechnol, 2005, 23(3): 313-320.
  • 4Iyer M, Berenji M, Templeton N S, et al. Noninvasive imaging of cationic lipid-mediated delivery of optical and PET reporter genes in living mice. Mol Ther, 2002, 6(4): 555-562.
  • 5Maggi A, Ciana P. Reporter mice and drug discovery and development. Nat Rev Drug Discov, 2005, 4(3): 249-255.
  • 6Rice B W, Cable M D, Nelson M B. In vivo imaging of light-emitting probes. J Biomed Opt, 2001, 6(4):432-440.
  • 7Edinger M, Cao Y A, Verneris M R, et al. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood, 2003,101 (2):640-648.
  • 8Minn A J, Kang Y, Serganova I, et al. Distinct organ-specific metastalic potential of individual breast cancer cells and primary tumors. J Clin Invest, 2005, 115:44-55.
  • 9Chen X Y, Conti P S, Moats R A. In vivo near-infrared fluorescence imaging of integrin αvβ3 in brain tumor xenografts.Cancer Res, 2004, 64:8009-8014.
  • 10Gao X H, Cui Y Y, Levenson R M, et al. In vivo cancer targeting and imaging with semiconductor quantum dots.Nat Biotechnol, 2004, 22:969-976.

共引文献32

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部